Skip to main content
Back
Watch Compare

Meihua International Medical Technologies Co., Ltd.

Data quality: 83%
MHUAF
OTC Manufacturing Measuring & Analyzing Instruments
$6.41
$0.00 (0.00%)
Mkt Cap: 5.48 M
Price
$6.41
Mkt Cap
5.48 M
Day Range
$6.41 — $6.41
52-Week Range
$2.05 — $64.00
Volume
1
Open $6.41
50D / 200D Avg
$9.21
30.39% below
50D / 200D Avg
$23.70
72.96% below

Quick Summary

Key Takeaways

Debt/Equity of 0.07 — conservative balance sheet
Generating 3.59 M in free cash flow
P/E of 0.59 — trading at a low valuation

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-6.73%
FCF Growth (3Y)N/A

Quality

Return on Equity
5.90%
Above sector avg (-51.02%)
ROIC5.61%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.07
Below sector avg (0.33)
Current Ratio5.71
Interest Coverage48.36

Valuation

PE (TTM)
0.59
Above sector avg (-1.98)
P/B Ratio0.03
EV/EBITDA1.45
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E 0.6 -2.0
P/B 0.0 5.1
ROE % 5.9 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E 0.1 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -6.73% Earnings Growth (3Y) 31.79%
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 9.27 M
ROE 5.90% ROA 5.02%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 3.59 M
ROIC 5.61% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.07 Current Ratio 5.71
Interest Coverage 48.36 Asset Turnover N/A
Working Capital 120.70 M Tangible Book Value 164.50 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.59 Forward P/E N/A
P/B Ratio 0.03 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1.45 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 65.37%
Market Cap 5.48 M Enterprise Value 16.93 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 4.19 OCF / Share 4.35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 38.67%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue — — 103.35 M 104.04 M
Net Income 10.84 M 11.63 M 6.24 M 20.95 M
EPS (Diluted) — 0.49 0.27 —
Gross Profit 33.30 M 33.20 M 38.10 M 39.81 M
Operating Income 14.31 M 14.67 M 10.80 M 26.26 M
EBITDA — — — —
R&D Expenses 3.46 M 2.75 M 2.96 M 2.73 M
SG&A Expenses — — — —
D&A — — 541,265.0 595,522.0
Interest Expense 247,615.0 3,468.0 191,198.0 180,744.0
Income Tax 2.79 M 3.46 M 4.71 M 5.28 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 186.24 M 171.92 M 163.58 M 136.86 M
Total Liabilities 27.26 M 25.08 M 24.90 M 29.09 M
Shareholders' Equity 158.98 M 146.33 M 138.12 M 107.77 M
Total Debt 7.95 M 8.05 M 6.09 M 5.18 M
Cash & Equivalents — 16.93 M 26.74 M 8.15 M
Current Assets 143.44 M 132.24 M 135.32 M 97.28 M
Current Liabilities 27.26 M 25.07 M 24.17 M 29.09 M